122 related articles for article (PubMed ID: 27491843)
1. A simple, effective approach for rapid development of high-throughput and reliable LC-MS/MS bioanalytical assays.
Yuan L; Aubry AF; Ji QC
Bioanalysis; 2016 Sep; 8(17):1809-22. PubMed ID: 27491843
[TBL] [Abstract][Full Text] [Related]
2. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
[TBL] [Abstract][Full Text] [Related]
3. A highly sensitive and selective LC-MS/MS method to quantify asunaprevir, an HCV NS3 protease inhibitor, in human plasma in support of pharmacokinetic studies.
Kandoussi H; Jiang H; Zeng J; Zheng N; Kadiyala P; Eley T; He B; Garimella T; Demers R; Cojocaru L; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2016 Feb; 119():145-51. PubMed ID: 26683987
[TBL] [Abstract][Full Text] [Related]
4. A rugged and accurate liquid chromatography-tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma.
Yuan L; Jiang H; Ouyang Z; Xia YQ; Zeng J; Peng Q; Lange RW; Deng Y; Arnold ME; Aubry AF
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():81-6. PubMed ID: 23435345
[TBL] [Abstract][Full Text] [Related]
5. Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urine.
Jiang H; Demers R; Kandoussi H; Burrell R; Eley T; Kadiyala P; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME; Zeng J
J Pharm Biomed Anal; 2015 Mar; 107():17-23. PubMed ID: 25562845
[TBL] [Abstract][Full Text] [Related]
6. Characterization of matrix effects in developing rugged high-throughput LC-MS/MS methods for bioanalysis.
Li F; Wang J; Jenkins R
Bioanalysis; 2016 May; 8(10):1021-34. PubMed ID: 27079811
[TBL] [Abstract][Full Text] [Related]
7. A rugged and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of BMS-790052 in plasma.
Jiang H; Zeng J; Deng Y; Xia YQ; Ouyang Z; Jemal M; Salcedo TW; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2064-72. PubMed ID: 21704571
[TBL] [Abstract][Full Text] [Related]
8. Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MS.
Liu A; Lute J; Gu H; Wang B; Trouba KJ; Arnold ME; Aubry AF; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():29-40. PubMed ID: 26209768
[TBL] [Abstract][Full Text] [Related]
9. A simplified and completely automated workflow for regulated LC-MS/MS bioanalysis using cap-piercing direct sampling and evaporation-free solid phase extraction.
Zheng N; Buzescu A; Pasas-Farmer S; Arnold ME; Ouyang Z; Jemal M; Peng Q; Van Vleet T; Zeng J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():64-74. PubMed ID: 23435343
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma.
Jiang H; Kandoussi H; Zeng J; Wang J; Demers R; Eley T; He B; Burrell R; Easter J; Kadiyala P; Pursley J; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2015 Mar; 107():409-18. PubMed ID: 25676854
[TBL] [Abstract][Full Text] [Related]
11. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.
Liu J; Yuan L; Liu G; Shen JX; Aubry AF; Arnold ME; Ji QC
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():85-91. PubMed ID: 25930207
[TBL] [Abstract][Full Text] [Related]
12. A rapid, accurate and robust UHPLC-MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies.
Zheng N; Zeng J; Akinsanya B; Buzescu A; Xia YQ; Ly V; Trouba K; Peng Q; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2013 Sep; 83():237-48. PubMed ID: 23770636
[TBL] [Abstract][Full Text] [Related]
13. A sensitive and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urine.
Jiang H; Zeng J; Kandoussi H; Liu Y; Wang X; Bifano M; Cojocaru L; Ryan J; Arnold ME
J Chromatogr A; 2012 Jul; 1245():117-21. PubMed ID: 22640838
[TBL] [Abstract][Full Text] [Related]
14. A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study.
Yuan L; Huang C; Liu-Kreyche P; Voronin K; Fancher RM; Allentoff A; Zheng N; Iyer R; Zhu L; Pillutla R; Ji QC
J Pharm Biomed Anal; 2019 Feb; 165():198-206. PubMed ID: 30553110
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate.
Yuan L; Basdeo S; Ji QC
J Pharm Biomed Anal; 2018 Aug; 157():36-43. PubMed ID: 29758468
[TBL] [Abstract][Full Text] [Related]
16. Post-pellet-digestion precipitation and solid phase extraction: A practical and efficient workflow to extract surrogate peptides for ultra-high performance liquid chromatography--tandem mass spectrometry bioanalysis of a therapeutic antibody in the low ng/mL range.
Gong C; Zheng N; Zeng J; Aubry AF; Arnold ME
J Chromatogr A; 2015 Dec; 1424():27-36. PubMed ID: 26525666
[TBL] [Abstract][Full Text] [Related]
17. Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry.
Ma Z; Li S; He D; Wang Y; Jiang H; Zhou H; Jin J; Lin N
Rapid Commun Mass Spectrom; 2020 May; 34(9):e8728. PubMed ID: 31960519
[TBL] [Abstract][Full Text] [Related]
18. Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3/NS4 protease inhibitor, in human plasma and human Tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection.
Anderson MD; Breidinger SA; Woolf EJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1047-56. PubMed ID: 19328051
[TBL] [Abstract][Full Text] [Related]
19. Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay.
Yuan L; Fu Y; Zhang D; Xia YQ; Peng Q; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():60-8. PubMed ID: 25151331
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma.
Nguyen R; Goodell JC; Shankarappa PS; Zimmerman S; Yin T; Peer CJ; Figg WD
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122641. PubMed ID: 33756448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
